Wealth Architects’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $547K | Sell |
1,090
-26
| -2% | -$12.5K | 0.04% | 137 |
|
|
2026
Q1 | $548K | Sell |
1,116
-11
| -1% | -$5.97K | 0.05% | 134 |
|
|
2025
Q4 | $653K | Sell |
1,127
-75
| -6% | -$42.4K | 0.06% | 128 |
|
|
2025
Q3 | $583K | Sell |
1,202
-8
| -0.7% | -$3.72K | 0.06% | 131 |
|
|
2025
Q2 | $491K | Sell |
1,210
-189
| -14% | -$79K | 0.05% | 138 |
|
|
2025
Q1 | $696K | Buy |
1,399
+159
| +13% | +$86.1K | 0.08% | 115 |
|
|
2024
Q4 | $645K | Sell |
1,240
-106
| -8% | -$58.3K | 0.07% | 105 |
|
|
2024
Q3 | $832K | Sell |
1,346
-12
| -0.9% | -$7.1K | 0.09% | 91 |
|
|
2024
Q2 | $751K | Sell |
1,358
-312
| -19% | -$179K | 0.09% | 96 |
|
|
2024
Q1 | $971K | Sell |
1,670
-66
| -4% | -$37K | 0.13% | 77 |
|
|
2023
Q4 | $921K | Sell |
1,736
-83
| -5% | -$40.2K | 0.13% | 76 |
|
|
2023
Q3 | $921K | Buy |
1,819
+16
| +0.9% | +$8.53K | 0.16% | 71 |
|
|
2023
Q2 | $941K | Sell |
1,803
-24
| -1% | -$13K | 0.16% | 70 |
|
|
2023
Q1 | $1.05M | Sell |
1,827
-1
| -0.1% | -$564 | 0.19% | 63 |
|
|
2022
Q4 | $1.01M | Sell |
1,828
-54
| -3% | -$28.6K | 0.19% | 61 |
|
|
2022
Q3 | $955K | Buy |
1,882
+139
| +8% | +$77.8K | 0.2% | 52 |
|
|
2022
Q2 | $947K | Buy |
1,743
+1
| +0.1% | +$550 | 0.19% | 59 |
|
|
2022
Q1 | $1.03M | Sell |
1,742
-68
| -4% | -$39.1K | 0.17% | 58 |
|
|
2021
Q4 | $1.21M | Buy |
1,810
+226
| +14% | +$141K | 0.21% | 50 |
|
|
2021
Q3 | $905K | Buy |
1,584
+2
| +0.1% | +$1.1K | 0.18% | 59 |
|
|
2021
Q2 | $798K | Buy |
1,582
+125
| +9% | +$59K | 0.16% | 62 |
|
|
2021
Q1 | $665K | Buy |
1,457
+29
| +2% | +$13.8K | 0.14% | 65 |
|
|
2020
Q4 | $665K | Sell |
1,428
-70
| -5% | -$32.8K | 0.15% | 60 |
|
|
2020
Q3 | $661K | Sell |
1,498
-32
| -2% | -$13.2K | 0.18% | 54 |
|
|
2020
Q2 | $554K | Buy |
1,530
+20
| +1% | +$6.7K | 0.16% | 64 |
|
|
2020
Q1 | $428K | Sell |
1,510
-13
| -0.9% | -$4.1K | 0.15% | 70 |
|
|
2019
Q4 | $495K | Buy |
1,523
+45
| +3% | +$13.6K | 0.14% | 64 |
|
|
2019
Q3 | $430K | Sell |
1,478
-93
| -6% | -$26.6K | 0.13% | 68 |
|
|
2019
Q2 | $461K | Buy |
1,571
+59
| +4% | +$16.3K | 0.14% | 64 |
|
|
2019
Q1 | $414K | Buy |
1,512
+153
| +11% | +$38.1K | 0.13% | 68 |
|
|
2018
Q4 | $304K | Sell |
1,359
-5
| -0.4% | -$1.17K | 0.11% | 87 |
|
|
2018
Q3 | $333K | Sell |
1,364
-13
| -0.9% | -$2.99K | 0.1% | 91 |
|
|
2018
Q2 | $285K | Hold |
1,377
| – | – | 0.09% | 94 |
|
|
2018
Q1 | $284K | Hold |
1,377
| – | – | 0.09% | 94 |
|
|
2017
Q4 | $261K | Sell |
1,377
-428
| -24% | -$82K | 0.09% | 105 |
|
|
2017
Q3 | $342K | Hold |
1,805
| – | – | 0.12% | 86 |
|
|
2017
Q2 | $314K | Hold |
1,805
| – | – | 0.12% | 87 |
|
|
2017
Q1 | $277K | Hold |
1,805
| – | – | 0.11% | 90 |
|
|
2016
Q4 | $255K | Hold |
1,805
| – | – | 0.11% | 96 |
|
|
2016
Q3 | $287K | Hold |
1,805
| – | – | 0.13% | 86 |
|
|
2016
Q2 | $266K | Sell |
1,805
-17
| -0.9% | -$2.51K | 0.13% | 91 |
|
|
2016
Q1 | $258K | Sell |
1,822
-4
| -0.2% | -$536 | 0.13% | 92 |
|
|
2015
Q4 | $259K | Hold |
1,826
| – | – | 0.13% | 97 |
|
|
2015
Q3 | $223K | Buy |
1,826
+23
| +1% | +$3K | 0.12% | 105 |
|
|
2015
Q2 | $234K | Buy |
+1,803
| New | +$235K | 0.13% | 106 |
|
Other funds holding TMO
Wealth Architects's TMO Position: Q2 2026 in Review
Wealth Architects reduced its Thermo Fisher Scientific (TMO) stake by 2.3% in Q2 2026, selling an estimated $12.5K and leaving 1,090 shares worth $547K. The position accounts for 0.04% of the portfolio, ranked #137.
Wealth Architects first reported a position in TMO in Q2 2015 and has held it in 45 quarters since. The position peaked at $1.21M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Wealth Architects held 1,090 shares of Thermo Fisher Scientific worth $547K as of Q2 2026.
- Wealth Architects sold 26 Thermo Fisher Scientific shares in Q2 2026, an estimated $12.5K.
- Thermo Fisher Scientific made up 0.04% of Wealth Architects's portfolio in Q2 2026, its #137 holding.
- Wealth Architects first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 45 quarters since.
- Wealth Architects's Thermo Fisher Scientific position peaked at $1.21M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Wealth Architects's 13F filing for Q2 2026, filed 23 Jul 2026.